Drug firm Abbott India has reported a 54.22 per cent rise in its net profit at Rs 180.35 crore for the June quarter of 2020. It had posted a net profit of Rs 116.94 crore a year ago.

Revenue from operations stood at Rs 1,064.27 crore for the quarter under consideration. It was Rs 998.89 crore for the same period a year ago.

Meanwhile, Drug firm Divi’s Laboratories has reported an 80.61 per cent rise in consolidated net profit at Rs 492.06 crore for the June quarter of 2020 mainly on account of robust sales.

The company had logged a profit of Rs 272.44 crore in the year-ago period, Divi’s Laboratories said in a filing.